JAKi and anti-IL-7R antibody had no effects on steady state BCL2L1 expression in mature T-ALL or ETP-ALL cells but did decrease MCL1 expression specifically in Zeb2Tg ETP-ALL cells (Fig. S3C). The gene discussed is MCL1; the disease is acute lymphoblastic leukemia.